One of the things that I’ve struggled with since I started working in biotech, and that a lot of the folks I talk to struggle with as well, is communicating the value of the kinds of things I write about here, particularly the more mundane aspects of biotech data, to founders and leaders. There’s no question that most of them are excited about the potential revolution that’s coming to biotech, or maybe has already started, around AI and ML, fueled by data. But the harder part - both for less technical decision makers to understand and for the rest of us to coherently explain - is what kinds of investments are fundamentally important to fueling this revolution vs. which are just frivolous vanity projects.
Is biotech data driven?
Is biotech data driven?
Is biotech data driven?
One of the things that I’ve struggled with since I started working in biotech, and that a lot of the folks I talk to struggle with as well, is communicating the value of the kinds of things I write about here, particularly the more mundane aspects of biotech data, to founders and leaders. There’s no question that most of them are excited about the potential revolution that’s coming to biotech, or maybe has already started, around AI and ML, fueled by data. But the harder part - both for less technical decision makers to understand and for the rest of us to coherently explain - is what kinds of investments are fundamentally important to fueling this revolution vs. which are just frivolous vanity projects.